Patents/Assignees

Genzyme Corporation

136 patents in portfolio

US11835434utility2023
Methods for Absolute Quantification of Low-abundance Polypeptides Using Mass Spectrometry
0 cites
US11814383utility2023
Crystalline Imidazo[4,5-b]pyridine Compound, Pharmaceutical Compositions, and Their Use in Treating Medical Conditions
0 cites
US11807690utility2023
Hyperglycosylated Binding Polypeptides
0 cites
US11801311utility2023
Inhibiting or Downregulating Glycogen Synthase by Creating Premature Stop Codons Using Antisense Oligonucleotides
0 cites
US11796546utility2023
Methods for Quantifying Drug Concentration in a Prodrug Composition
0 cites
US11793749utility2023
Pharmaceutical Formulations of Tropomyosin Related Kinase (TRK) Inhibitors
0 cites
US11781137utility2023
Variant Rnai
0 cites
US11754573utility2023
Methods for the Quantitation of Polypeptides
0 cites
US11697690utility2023
Site-specific Glycoengineering of Targeting Moieties
0 cites
US11698377utility2023
Methods for Detecting AAV
0 cites
US11685943utility2023
Early Post-transfection Isolation of Cells (EPIC) for Biologics Production
0 cites
US11672802utility2023
Induction of Immune Tolerance by Using Methotrexate
0 cites
US11639887utility2023
Analytical Ultracentrifugation for Characterization of Recombinant Viral Particles
0 cites
US11635363utility2023
FLARE (flow Cytometry Attenuated Reporter Expression) Technology for Rapid Bulk Sorting
0 cites
US11603529utility2023
Variant Rnai
0 cites
US11554161utility2023
Gene Therapy for Amyotrophic Lateral Sclerosis and Other Spinal Cord Disorders
0 cites

← PreviousPage 7 of 7